Načítá se...
Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders
INTRODUCTION: HE4 is a novel biomarker for ovarian cancer. This study measured HE4 and CA125 levels in women with benign gynecologic disorders. METHODS: Sera were obtained from women prior to surgery for a pelvic mass and HE4 and CA125 levels were determined. The proportions of patients with elevate...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3985608/ https://ncbi.nlm.nih.gov/pubmed/22284961 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajog.2011.12.029 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|